ZhuZhou QianJin Pharmaceutical Co.,Ltd (SHA:600479)

Market Cap	5.45B +22.9%
Revenue (ttm)	3.63B -0.0%
Net Income	286.29M +24.1%
EPS	0.66 +19.1%
Shares Out	492.21M
PE Ratio	16.66
Forward PE	n/a
Dividend	0.36 (3.40%)
Ex-Dividend Date	Jul 25, 2025

Volume	21,682,437
Average Volume	7,538,669
Open	10.80
Previous Close	10.58
Day's Range	10.74 - 11.07
52-Week Range	9.86 - 11.53
Beta	0.33
RSI	61.34
Earnings Date	Apr 29, 2026

About SHA:600479

ZhuZhou QianJin Pharmaceutical Co.,Ltd researches, develops, produces, and sells traditional Chinese medicines, chemicals and API, and TCM derivatives in China. The company offers TCM products, chemical medicine, derivative products, and hygienic products, including gynaecological and baby nursing, and maternity pad/ maternity package. ZhuZhou QianJin Pharmaceutical Co.,Ltd was founded in 1966 and is headquartered in Zhuzhou, China.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1966
• Employees: 5,270
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 600479

Financial Performance

In 2025, SHA:600479's revenue was 3.63 billion, a decrease of -0.03% compared to the previous year's 3.63 billion. Earnings were 286.29 million, an increase of 24.07%.